COA library
Every lot,
on the record.
Search certificates of analysis by product name or lot number. Every file is the original PDF issued by Telehealth Peptides and is permanently archived — withdrawn SKUs included.
32 records
| Product | Lot | Formula | Purity (HPLC) | Analyzed | Status | |
|---|---|---|---|---|---|---|
| BPC-157 | ABL-BPC-2601 | C62H98N16O22 | 99.82% | 2026-04-10 | PASS | |
| BPC-157 | ABL-BPC-2512 | C62H98N16O22 | 99.69% | 2026-03-13 | PASS | |
| BPC-157 | ABL-BPC-2510 | C62H98N16O22 | 99.56% | 2026-02-16 | PASS | |
| BPC-157 | ABL-BPC-2508 | C62H98N16O22 | 99.43% | 2026-01-19 | PASS | |
| TB-500 | ABL-TB5-2602 | C212H350N56O78S | 99.82% | 2026-04-10 | PASS | |
| TB-500 | ABL-TB5-2511 | C212H350N56O78S | 99.69% | 2026-03-13 | PASS | |
| TB-500 | ABL-TB5-2509 | C212H350N56O78S | 99.56% | 2026-02-16 | PASS | |
| GHK-Cu | ABL-GHK-2601 | C14H22CuN6O4 | 99.82% | 2026-04-10 | PASS | |
| GHK-Cu | ABL-GHK-2510 | C14H22CuN6O4 | 99.69% | 2026-03-13 | PASS | |
| CJC-1295 (no DAC) | ABL-CJC-2602 | C152H252N44O42 | 99.82% | 2026-04-10 | PASS | |
| CJC-1295 (no DAC) | ABL-CJC-2512 | C152H252N44O42 | 99.69% | 2026-03-13 | PASS | |
| CJC-1295 (no DAC) | ABL-CJC-2509 | C152H252N44O42 | 99.56% | 2026-02-16 | PASS | |
| Ipamorelin | ABL-IPA-2603 | C38H49N9O5 | 99.82% | 2026-04-10 | PASS | |
| Ipamorelin | ABL-IPA-2601 | C38H49N9O5 | 99.69% | 2026-03-13 | PASS | |
| Ipamorelin | ABL-IPA-2510 | C38H49N9O5 | 99.56% | 2026-02-16 | PASS | |
| Tesamorelin | ABL-TES-2602 | C223H346N44O69S | 99.82% | 2026-04-10 | PASS | |
| Tesamorelin | ABL-TES-2511 | C223H346N44O69S | 99.69% | 2026-03-13 | PASS | |
| Semaglutide | ABL-SEM-2604 | C187H291N45O59 | 99.82% | 2026-04-10 | PASS | |
| Semaglutide | ABL-SEM-2602 | C187H291N45O59 | 99.69% | 2026-03-13 | PASS | |
| Semaglutide | ABL-SEM-2512 | C187H291N45O59 | 99.56% | 2026-02-16 | PASS | |
| Semaglutide | ABL-SEM-2510 | C187H291N45O59 | 99.43% | 2026-01-19 | PASS | |
| Tirzepatide | ABL-TZP-2603 | C225H348F2N48O68 | 99.82% | 2026-04-10 | PASS | |
| Tirzepatide | ABL-TZP-2601 | C225H348F2N48O68 | 99.69% | 2026-03-13 | PASS | |
| Tirzepatide | ABL-TZP-2510 | C225H348F2N48O68 | 99.56% | 2026-02-16 | PASS | |
| Retatrutide | ABL-RET-2602 | C221H343N51O64 | 99.82% | 2026-04-10 | PASS | |
| Retatrutide | ABL-RET-2512 | C221H343N51O64 | 99.69% | 2026-03-13 | PASS | |
| MOTS-c | ABL-MTC-2601 | C100H162N28O25S | 99.82% | 2026-04-10 | PASS | |
| MOTS-c | ABL-MTC-2510 | C100H162N28O25S | 99.69% | 2026-03-13 | PASS | |
| Epitalon | ABL-EPI-2602 | C14H22N4O9 | 99.82% | 2026-04-10 | PASS | |
| Epitalon | ABL-EPI-2511 | C14H22N4O9 | 99.69% | 2026-03-13 | PASS | |
| PT-141 | ABL-PT1-2602 | C50H68N14O10 | 99.82% | 2026-04-10 | PASS | |
| PT-141 | ABL-PT1-2510 | C50H68N14O10 | 99.69% | 2026-03-13 | PASS |